Ewelina Weglarz-Tomczak (UvA): Lysosomal protease inhibitors for Alzheimer’s
Ewelina Weglarz-Tomczak (UvA): Novel lysosomal protease inhibitors for the treatment of Alzheimer’s disease
Highly specified proteases are the key regulators in the molecular mechanism of neurodegeneration in Alzheimer’s disease. AI-powered technology developed by NatInLab has led to the discovery of how those proteases are controlled in the human organism. Based on this knowledge, developing novel, highly effective and safe inhibitors of these proteases is possible. The project aims to deliver new agents against Alzheimer’s and possibly other neurodegenerative diseases as the next step. The novel drugs are expected to be curative and show minimal side effects.
Explore other Cases:
Georges Janssens (Amsterdam UMC): My Health Buddy
Georges Janssens (Amsterdam UMC): MyHeBu (My Health Buddy), a wearable device-based and AI-powered digital twin to track your health and aging. Many people are tracking all of their health data using wearable devices, but it’s not really giving them answers to simple questions like: ‘How often should I exercise?’, or ‘Is my high protein diet […]
Paul Merkus (Amsterdam UMC): BoneMRI of the head
Paul Merkus (Amsterdam UMC): BoneMRI of the head There are many young patients that face deafness and need surgery to be able to hear. Before the surgery, the ENT-surgeon currently needs two scans: an MRI to visualize the soft tissues like nerves, and a CT scan to show the bony structures. However, the CT scanning […]
Siwan Aberkane (VU): PULSE Sports
Siwan Aberkane (VU): PULSE Sports – App-connected sportswear allowing athletes to monitor their body & mind, to maximise performance & avoid over-training. Millions of athletes worldwide are in a crisis, struggling with extreme physical and mental issues. Research experts and athletes themselves confirme that existing tools are too superficial and inaccurate for the prevention of […]